Studies show that postpartum depression (PPD) affects at least 10 percent of women and that many depressed mothers do not get proper treatment. These mothers might cope with their baby… Read More
Key Message Temporal and sequential pattern of Alzheimer’s disease (AD) biomarkers presents a framework for in-vivo staging of disease progression. Accumulated evidence supports the temporal and sequential patterns proposed by… Read More
Mental Illness Microaggressions Scale – Perpetrator Version (MIMS-P) is a 17-item instrument designed to measure microaggressions endorsed by perpetrators against a socially marginalized group and demonstrates strong psychometric properties. The… Read More
The Pain Medication Questionnaire (PMQ) is a 26-item instrument designed to identify patients on a continuum from low to high risk for opioid misuse. The original study which validated the… Read More
The Cut Down, Annoyed, Guilty, Eye-Opener (CAGE) was designed to screen patient risk for alcohol abuse and dependence in the clinical setting. This version of the tool is a brief… Read More
The Hamilton Depression Rating Scale (HAM-D; HRSD; HDRS), designed in 1960, has become one of the most widely utilized rating scales intended to assess depression disorder symptom severity and change.… Read More
The Brief Resilience Scale (BRS) differs from previous scales measuring resilience in that it does not attempt to identify or measure personal characteristics and/or social resources that individuals may possess… Read More
The Relapse Risk Assessment in Patients with Schizophrenia (RASP) was designed to identify changes in patients living with schizophrenia by measuring symptomology and functional status in order to assess relapse… Read More